Publication | Open Access

Objective responses to first-line neoadjuvant carboplatin–paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory analysis of a randomised, phase 3 trial

Gastrointestinal OncologyMedicinePost-hoc Exploratory AnalysisGynecologyFallopian TubeCancer TreatmentOncologyRadiation OncologyGynecology OncologyOvarian CancerObjective Responses